Angeloyloxaartabsin

Details

Top
Internal ID b1a8c38f-0bfe-4b14-9990-4bca6ba53d3c
Taxonomy Organoheterocyclic compounds > Cycloheptafurans
IUPAC Name [(2S,5S,6R,7S,9S)-9-hydroxy-5,9,13-trimethyl-4-oxo-3,12-dioxatricyclo[8.3.0.02,6]trideca-1(13),10-dien-7-yl] (Z)-2-methylbut-2-enoate
SMILES (Canonical) CC=C(C)C(=O)OC1CC(C2=COC(=C2C3C1C(C(=O)O3)C)C)(C)O
SMILES (Isomeric) C/C=C(/C)\C(=O)O[C@H]1C[C@](C2=COC(=C2[C@@H]3[C@@H]1[C@@H](C(=O)O3)C)C)(C)O
InChI InChI=1S/C19H24O6/c1-6-9(2)17(20)24-13-7-19(5,22)12-8-23-11(4)15(12)16-14(13)10(3)18(21)25-16/h6,8,10,13-14,16,22H,7H2,1-5H3/b9-6-/t10-,13-,14+,16-,19-/m0/s1
InChI Key UUYOHEAYCPQMKY-PORWQSLVSA-N
Popularity 0 references in papers

Physical and Chemical Properties

Top
Molecular Formula C19H24O6
Molecular Weight 348.40 g/mol
Exact Mass 348.15728848 g/mol
Topological Polar Surface Area (TPSA) 86.00 Ų
XlogP 2.30
Atomic LogP (AlogP) 2.93
H-Bond Acceptor 6
H-Bond Donor 1
Rotatable Bonds 2

Synonyms

Top
DTXSID301099990
142449-63-6
2-Butenoic acid, 2-methyl-, (3S,3aR,4S,6S,9bS)-2,3,3a,5,6,9b-hexahydro-6-hydroxy-3,6,9-trimethyl-2-oxo-4H-cyclohepta[2,1-b:3,4-c']difuran-4-yl ester, (2Z)-

2D Structure

Top
2D Structure of Angeloyloxaartabsin

3D Structure

Top

ADMET Properties (via admetSAR 2)

Top
Target Value Probability (raw) Probability (%)
Human Intestinal Absorption + 0.9884 98.84%
Caco-2 + 0.6334 63.34%
Blood Brain Barrier + 0.6250 62.50%
Human oral bioavailability - 0.5143 51.43%
Subcellular localzation Mitochondria 0.5765 57.65%
OATP2B1 inhibitior - 1.0000 100.00%
OATP1B1 inhibitior + 0.8931 89.31%
OATP1B3 inhibitior + 0.8754 87.54%
MATE1 inhibitior - 0.8600 86.00%
OCT2 inhibitior - 0.9250 92.50%
BSEP inhibitior + 0.5699 56.99%
P-glycoprotein inhibitior - 0.5810 58.10%
P-glycoprotein substrate - 0.7011 70.11%
CYP3A4 substrate + 0.6516 65.16%
CYP2C9 substrate - 1.0000 100.00%
CYP2D6 substrate - 0.8968 89.68%
CYP3A4 inhibition - 0.7441 74.41%
CYP2C9 inhibition - 0.7565 75.65%
CYP2C19 inhibition - 0.8296 82.96%
CYP2D6 inhibition - 0.9463 94.63%
CYP1A2 inhibition - 0.6712 67.12%
CYP2C8 inhibition - 0.7865 78.65%
CYP inhibitory promiscuity - 0.8875 88.75%
UGT catelyzed - 0.5000 50.00%
Carcinogenicity (binary) - 0.9000 90.00%
Carcinogenicity (trinary) Danger 0.4503 45.03%
Eye corrosion - 0.9804 98.04%
Eye irritation - 0.8450 84.50%
Skin irritation - 0.6790 67.90%
Skin corrosion - 0.9101 91.01%
Ames mutagenesis - 0.5500 55.00%
Human Ether-a-go-go-Related Gene inhibition + 0.7510 75.10%
Micronuclear + 0.5200 52.00%
Hepatotoxicity + 0.6502 65.02%
skin sensitisation - 0.6589 65.89%
Respiratory toxicity + 0.6889 68.89%
Reproductive toxicity + 0.6778 67.78%
Mitochondrial toxicity + 0.8250 82.50%
Nephrotoxicity + 0.5179 51.79%
Acute Oral Toxicity (c) II 0.3930 39.30%
Estrogen receptor binding + 0.6429 64.29%
Androgen receptor binding + 0.6319 63.19%
Thyroid receptor binding + 0.7098 70.98%
Glucocorticoid receptor binding + 0.6071 60.71%
Aromatase binding - 0.6663 66.63%
PPAR gamma + 0.5544 55.44%
Honey bee toxicity - 0.7364 73.64%
Biodegradation - 0.8250 82.50%
Crustacea aquatic toxicity - 0.5400 54.00%
Fish aquatic toxicity + 0.9567 95.67%

Targets

Top

Proven Targets:

CHEMBL ID UniProt ID Name Min activity Assay type Source
No proven targets yet!

Predicted Targets (via Super-PRED):

CHEMBL ID UniProt ID Name Probability Model accuracy
CHEMBL5619 P27695 DNA-(apurinic or apyrimidinic site) lyase 97.90% 91.11%
CHEMBL3108638 O15164 Transcription intermediary factor 1-alpha 93.32% 95.56%
CHEMBL1293249 Q13887 Kruppel-like factor 5 91.01% 86.33%
CHEMBL1806 P11388 DNA topoisomerase II alpha 88.52% 89.00%
CHEMBL3038477 P67870 Casein kinase II alpha/beta 87.74% 99.23%
CHEMBL4203 Q9HAZ1 Dual specificity protein kinase CLK4 84.97% 94.45%
CHEMBL253 P34972 Cannabinoid CB2 receptor 84.78% 97.25%
CHEMBL3251 P19838 Nuclear factor NF-kappa-B p105 subunit 81.79% 96.09%
CHEMBL241 Q14432 Phosphodiesterase 3A 80.16% 92.94%

Cross-Links

Top
PubChem 102008484
NPASS NPC20836
LOTUS LTS0225515
wikiData Q105279670